| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00630370 Details | 2009-06-17 Interventional | 2 | 6 | ATI 7505 Syndrome Post Prandial D… | - - | |||
| NCT00501241 Details | 2009-06-17 Interventional | 2 | - | ATI 7505 Constipation Chronic Constip… | - - | |||
| NCT00397657 Details | 2009-06-17 Interventional | 4 | - | Ezetimibe Niacin Atherosclerosis | Independent steering committee has stopped the trial based on results of a prespecified,
blinded interim analysis. It was not stopped due to safety concerns. - | |||
| NCT00915616 Details | 2009-06-08 Interventional | 3 | - | Melatonin Gastroesophagea… Gastroesophagea… | - - | |||
| NCT00251095 Details | 2009-06-04 Interventional | 3 | 821 | Paclitaxel Breast Neoplasm… Breast Neoplasm | Failed primary endpoint - | |||
| NCT00904852 Details | 2009-05-20 Interventional | 1 | - | Bevacizumab Temozolomide Glioblastoma Glioblastoma Mu… | - - | |||
| NCT00436722 2005-005635-10 Details | 2009-05-20 Interventional | 2 | - | Antilymphocyte … Immunoglobulins Liver Diseases | Experimental arm (induction + low dose tacrolimus) not effective. - | |||
| NCT00297076 Details | 2009-05-18 Interventional | 3 | - | Aplaviroc HIV Infections HIV Infection | - - | |||
| NCT00437489 Details | 2009-05-11 Interventional | 4 | 49 | Insulin Insulin, Globin… Diabetes Mellit… Diabetes Mellit… | This protocol was terminated not for safety reasons, but because Pfizer decided to return the
worldwide rights for Exubera to Nektar, on 18 October 2007. As a result of Pfizer's decision (18Oct2007) to return the worldwide rights for Exubera (insulin human [rDNA origin]) Inhalation Powder) to Nektar, from which Pfizer licensed inhaled insulin technology, it was decided to terminate this study. | |||
| NCT00683267 Details | 2009-05-04 Interventional | 2 | 118 | Capsaicin Arthroplasty | Enrollment of patients has halted prematurely and will not resume. No future patients will be
enrolled or treated. - | |||
| NCT00672568 Details | 2009-05-04 Interventional | 2 | 24 | Capsaicin Rotator Cuff Re… | Study has been halted after completing Stage 1, for corporate reasons. No future patients will
be enrolled or treated. - | |||
| NCT00435448 Details | 2009-04-29 Interventional | 3 | - | Lonidamine Hyperplasia Prostatic Hyper… Benign Prostati… Enlarged Prosta… | - - | |||
| NCT00237536 Details | 2009-04-29 Interventional | 2 | - | Lonidamine Hyperplasia Prostatic Hyper… Benign Prostati… | - - | |||
| NCT00496158 Details | 2009-04-27 Interventional | 3 | - | Adefovir Clevudine Hepatitis Hepatitis A Hepatitis B Hepatitis, Chro… Chronic Hepatit… | The study was terminated in the interest of patient safety. - | |||
| NCT00496002 Details | 2009-04-27 Interventional | 3 | - | Adefovir Clevudine Hepatitis Hepatitis A Hepatitis B Hepatitis, Chro… Chronic Hepatit… | The study was terminated in the interest of patient safety. - | |||
| NCT00237900 Details | 2009-04-23 Interventional | 1/2 | - | Fluorouracil Gefitinib Leucovorin Stomach Neoplas… Subjects With R… | - - | |||
| NCT00261352 Details | 2009-04-22 Interventional | 3 | - | Fenofibrate Metformin Diabetes Mellit… Type 2 Diabetes | The development program has been terminated - | |||
| NCT00251953 2004-000348-25 Details | 2009-04-22 Interventional | 3 | - | Metformin Diabetes Mellit… Type 2 Diabetes | The development program has been terminated - | |||
| NCT00242372 Details | 2009-04-22 Interventional | 3 | - | Insulin Diabetes Mellit… Type 2 Diabetes… | The development program has been terminated - | |||
| NCT00710216 Details | 2009-04-20 Interventional | 4 | - | Lamivudine Telbivudine Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… | Sponsor withdraw - |